Ignite Creation Date:
2024-10-25 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06538012
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-31
Brief Title:
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
Sponsor:
Organization:
None